Company news

Henan Taloph Pharmaceutical Stock Co. Ltd. Class A (SSE:600222) news

Henan Taloph Pharmaceutical Stock Co. Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: "Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement…

Henan Taloph Pharmaceutical Stock Co. Ltd. Class A (SSE:600222) news

Press releases & updates

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Progress in Providing Guarantee for the Financing of Wholly-owned Subsidiary

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Successive Freezing of Shares Held by Shareholder Holding More Than 5% of the Shares

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Change in Accounting Policies

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Completion of Redemption of the 1st Tranche of Super Short-Term Commercial Paper for 2026

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Issuance Results of the 2nd Tranche of Super Short-term Commercial Paper for 2026

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Progress in Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Financing of Subsidiaries

"Henan Taloph Pharmaceutical Stock Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Completion of the Industrial and Commercial Change Registration of the Legal Representative

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on the Resignation of the Chairman, the Election of the Chairman, the Change of Legal Representative, and the By-election of Members of Special Committees of the Board of Directors

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on the Completion of Industrial and Commercial Registration for the Change in Registered Capital and Renewal of Business License

"Henan Taloph Pharmaceutical Stock Co., Ltd."Announcement on Cancellation of Repurchased Shares and Share Changes

Announcement on Rotary Freezing of Shares Held by Shareholder with Over 5% Shares

Announcement on Transfer of Part of Committed Capital Contribution in Sub-Fund by Zhengzhou Longhua Pharmaceutical Industry Fund Partnership (Limited Partnership) and Fund Progress

Announcement on Providing Guarantee for Financing of Wholly-owned and Holding Subsidiary

Announcement on Canceling Repurchased Shares and Decreasing Registered Capital and Notifying to Creditors

Announcement on Convening the Q1 2026 Performance Briefing

Notice on Convening the 2025 Annual General Meeting

Report for Q1 2026

Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing

Announcement on 2025 Annual Profit Distribution Plan

Announcement on Progress in Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries

Announcement on Completion of Redemption of the Phase I Ultra-short-term Financing Bonds for 2025

Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2026

Announcement on Progress in Receiving the "Decision on No Further Review of the Anti-Monopoly Examination for Concentration of Undertakings" and Proposed Change of Controlling Shareholder and Actual Controller

Announcement on Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries

Announcement on Progress in Providing Guarantee for Financing of Subordinated Holding Subsidiary

Announcement on Change of "Drug Manufacturing License"

Announcement on Implementation of Dividend Distribution for Q1-Q3 2025

Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management

Plan for Issuing A-shares to Specific Objects in 2025

Announcement on Continued Stock Suspension Due to Controlling Shareholder's Planning of Major Matters

Announcement on Stock Suspension Due to Controlling Shareholder's Planning of Major Matters

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License for Wholly-owned Subsidiary

Announcement on Progress in Joint Acquisition of an Industrial Fund Interest with Related Parties and Change of Fund Manager

Announcement on Completion and Termination of Stock Sales under the Phase III Employee Stock Ownership Plan

Announcement on Resolutions of the 4th Meeting of the 10th Board of Directors

Announcement on the Rotary Freezing and Judicial Marking of Shares Held by Shareholders with Over 5% Shares

Announcement on Progress in Providing Guarantee for Financing of Wholly-owned and Holding Subsidiary

Announcement on Progress in Receiving Financial Support from the Indirect Controlling Shareholder and Related Party Transaction

Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2025

Announcement on Accepting the Guarantee from Indirect Controlling Shareholder and Paying Guarantee Fee as well as Related Party Transactions

Announcement on Approval for Registration of Ultra-short-term Financing Bonds

Announcement on Completing Industrial and Commercial Change Registration of Legal Representative

2025 Semi-annual Report

Announcement on Electing Employee Representative Director

Announcement on Election of Board of Directors at Expiry of Term of Office

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

Announcement on Resolutions of the 32nd Meeting of the 9th Board of Directors

Announcement on Progress in Providing Guarantee for Financing of Holding Subsidiary